HLB Genex Overview
- Year Founded
-
2000
- Status
-
Public
- Employees
-
78
- Stock Symbol
-
187420
- Investments
-
4
- Share Price
-
$1.31
- (As of Monday Closing)
HLB Genex General Information
Description
HLB Genex Inc, formerly GenoFocus Inc is a high-throughput protein evolution company engaged in the development, manufacture, and distribution of enzymes like Lactazyme, chitizyme, and lipase. It develops enzyme solutions for specialty food, eco-friendly processes, biopharmaceuticals, cosmeceuticals, and agriculture.
Contact Information
Website
www.hlbgenex.comCorporate Office
- 65 Techno 1-ro, Yuseong-gu
- Daejeon, 34014
- South Korea
Corporate Office
- 65 Techno 1-ro, Yuseong-gu
- Daejeon, 34014
- South Korea
HLB Genex Timeline
HLB Genex Stock Performance
As of 16-Nov-2026, HLB Genex’s stock price is $1.31. Its current market cap is $42.9M with 32.6M shares.
(As of Monday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $1.31 | $1.37 | $0.88 - $2.42 | $42.9M | 32.6M | 375K | $0.19 |
HLB Genex Financials Summary
As of 30-Sep-2026, HLB Genex has a trailing 12-month revenue of $32.4M.
|
In Thousands, USD |
TTM 30-Sep-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | 63,409 | 62,066 | 97,727 | 105,446 |
| Revenue | 32,354 | 30,475 | 25,967 | 20,657 |
| EBITDA | 14,047 | 26,727 | (6,359) | 6,324 |
| Net Income | 5,415 | 15,874 | (13,799) | (2,256) |
| Total Assets | 85,423 | 94,325 | 99,297 | 75,940 |
| Total Debt | 23,209 | 30,225 | 30,261 | 48,377 |
HLB Genex Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
HLB Genex Patents
HLB Genex Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2025095595-A1 | Superoxide dismutase and uses thereof for preventing or treating kidney injury | Inactive | 30-Oct-2023 | ||
| WO-2024049280-A1 | Bacillus species strain expressing superoxide dismutase, bacillus species strain spore and/or superoxide dismutase, and use thereof for preventing or treating of fibrotic disease | Inactive | 01-Sep-2022 | ||
| WO-2024049280-A9 | Bacillus species strain expressing superoxide dismutase, bacillus species strain spore and/or superoxide dismutase, and use thereof for preventing or treating of fibrotic disease | Inactive | 01-Sep-2022 | ||
| JP-2025517375-A | Superoxide dismutase and its use for preventing or treating mucositis | Pending | 16-May-2022 | ||
| JP-2025518540-A | Superoxide dismutase and its use for the prevention or treatment of diabetic retinopathy or uveitis | Pending | 16-May-2022 | A61P31/00 |
HLB Genex Signals
HLB Genex Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
HLB Genex Investments & Acquisitions (4)
HLB Genex’s most recent deal was a Corporate with ACA Next for . The deal was made on 28-May-2025.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| ACA Next | 28-May-2025 | Corporate | Other Commercial Services | ||
| Korea Land and Housing (Industrial Complex in Daejeon, South Korea) | 25-Apr-2021 | Corporate Asset Purchase | Buildings and Property | ||
| Biobab AiBIO | 01-Apr-2019 | Corporate | Drug Discovery | ||
| GF Fermentec | 09-Mar-2017 | Merger/Acquisition | Discovery Tools (Healthcare) |
HLB Genex ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Pharmaceuticals
Industry
Rank
Percentile
Biotechnology
Subindustry
Rank
Percentile
HLB Genex Affiliates
Subsidiaries (1)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| GF Fermentec | Sejong, South Korea | 2000 |
HLB Genex FAQs
-
When was HLB Genex founded?
HLB Genex was founded in 2000.
-
Where is HLB Genex headquartered?
HLB Genex is headquartered in Daejeon, South Korea.
-
What is the size of HLB Genex?
HLB Genex has 78 total employees.
-
What industry is HLB Genex in?
HLB Genex’s primary industry is Drug Discovery.
-
Is HLB Genex a private or public company?
HLB Genex is a Public company.
-
What is HLB Genex’s stock symbol?
The ticker symbol for HLB Genex is 187420.
-
What is the current stock price of HLB Genex?
As of 16-Nov-2026 the stock price of HLB Genex is $1.31.
-
What is the current market cap of HLB Genex?
The current market capitalization of HLB Genex is $42.9M.
-
What is HLB Genex’s current revenue?
The trailing twelve month revenue for HLB Genex is $32.4M.
-
What is HLB Genex’s annual earnings per share (EPS)?
HLB Genex’s EPS for 12 months was $0.19.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process